Language:

Primary Prevention of Cardiovascular Disease in Diabetes Mellitus

Journal of the American College of Cardiology, 2017-08, Vol.70 (7), p.883-893 [Peer Reviewed Journal]

2017 American College of Cardiology Foundation ;Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Aug 15, 2017 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2017.07.001 ;PMID: 28797359

Full text available

Citations Cited by

Actions
1. Add to My Research
2. Remove from My Research
3. E-mail
4. Print
5. Permalink
6. Citation
7. EasyBib
8. EndNote
9. RefWorks
10. Delicious
11. Export RIS
12. Export BibTeX

Title:
Primary Prevention of Cardiovascular Disease in Diabetes Mellitus
Author: Newman, Jonathan D. ; Schwartzbard, Arthur Z. ; Weintraub, Howard S. ; Goldberg, Ira J. ; Berger, Jeffrey S.
Subjects: Adults ; Aspirin ; Blood ; Blood pressure ; Cardiovascular disease ; Cardiovascular diseases ; Cardiovascular Diseases - epidemiology ; Cardiovascular Diseases - etiology ; Cardiovascular Diseases - prevention & control ; Cholesterol ; Diabetes ; Diabetes mellitus ; Diabetes Mellitus, Type 2 - complications ; Diabetes Mellitus, Type 2 - epidemiology ; Diet ; Disease prevention ; Exercise ; Global Health ; Glucose ; Guidelines ; Health risk assessment ; Health risks ; Humans ; Intervention ; Lifestyles ; Lipids ; Morbidity ; Mortality ; Nutrition ; Nutrition research ; Patients ; Physical fitness ; Prevention ; primary prevention ; Primary Prevention - methods ; Risk Factors ; Risk management ; Smoking cessation ; type 2 diabetes ; Weight control
Is Part Of: Journal of the American College of Cardiology, 2017-08, Vol.70 (7), p.883-893
Description: Type 2 diabetes mellitus (T2D) is a major risk factor for cardiovascular disease (CVD), the most common cause of death in T2D. Yet, <50% of U.S. adults with T2D meet recommended guidelines for CVD prevention. The burden of T2D is increasing: by 2050, approximately 1 in 3 U.S. individuals may have T2D, and patients with T2D will comprise an increasingly large proportion of the CVD population. The authors believe it is imperative that we expand the use of therapies proven to reduce CVD risk in patients with T2D. The authors summarize evidence and guidelines for lifestyle (exercise, nutrition, and weight management) and CVD risk factor (blood pressure, cholesterol and blood lipids, glycemic control, and the use of aspirin) management for the prevention of CVD among patients with T2D. The authors believe appropriate lifestyle and CVD risk factor management has the potential to significantly reduce the burden of CVD among patients with T2D. [Display omitted]
Publisher: United States: Elsevier Inc
Language: English
Identifier: ISSN: 0735-1097
EISSN: 1558-3597
DOI: 10.1016/j.jacc.2017.07.001
PMID: 28797359
Source: GFMER Free Medical Journals
MEDLINE
Alma/SFX Local Collection

Back to results list


INSPIRE LIBRARY - TON DUC THANG UNIVERSITY	(84-028) 37 755 057	Feedback
19 Nguyen Huu Tho St. Dist.7, HCM	thuvien@tdtu.edu.vn	Feedback

Primary Prevention of Cardiovascular Disease in Diabetes Mellitus

2017 American College of Cardiology Foundation ;Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Aug 15, 2017 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2017.07.001 ;PMID: 28797359

Searching Remote Databases, Please Wait